Livongo Health, a Mountain View, Calif.-based consumer digital health company focused on chronic conditions, completed a $44.5m Series C financing round.
Backers included Merck Global Health Innovation Fund; Cowen Private Investments; Sapphire Ventures; Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts; Wanxiang America Corporation; and others as well as existing investors General Catalyst, Kleiner Perkins Caufield & Byers (KPCB), DFJ, and 7wire Ventures.
The company intends to use the new funds to accelerate the launch of new products and services, and to expand into new market segments.
Led by Glen Tullman, Chief Executive Officer, Livongo Health provides a diabetes management platform to self-insured employers, payers, and healthcare providers featuring a cellular, two-way interactive glucose meter that transmits data and messaging real-time, a smart cloud that provides personalized analytics and insights, and certified diabetes educators linked to the patient’s care team including family, friends, and medical professionals.
Clients include Lowe’s, which has deployed Livongo Health’s solution to a group of employees and their family members diagnosed with diabetes in Lowe’s North Carolina, South Carolina, and Alabama markets last September. Based on strong early results, Lowe’s expanded access to Livongo for Diabetes in March to employees and dependents nationwide.